Howard E. Davis, Ph.D.

Howard E. Davis, Ph.D. has a diverse range of work experience in the biotechnology and pharmaceutical industries. Howard E.'smost recent position is as the Chief Executive Officer of Akamis Bio, a role they began in 2022. Prior to this, they served as the Chief Operating Officer of Third Harmonic Bio from 2020 to 2022, where they played a critical leadership role in the company's early stages, including fundraising and business development. From 2019 to 2020, they were the Vice President of Corporate Development at Sophren Therapeutics, where they were responsible for fundraising and strategic leadership. Howard also worked at Flagship Pioneering as a Principal from 2018 to 2019, managing strategic corporate partnerships. Before that, they held various roles at Biogen, including Vice President and Asset Executive, Member of the Board of Directors for the Biogen Foundation, and Chief of Staff to the CEO. Howard also gained experience at Novartis, where they were a Global Brand Director and Associate Brand Director, as well as a Sr. Manager of Strategic Planning. Howard E. began their career at The Boston Consulting Group as a Project Leader, where they worked with pharmaceutical and biotechnology companies on corporate strategy and organizational transformation. Howard also spent time at Global Prior Art, where they were a Vice President in the Biotechnology & Medical Device Group, providing intellectual property consulting support. Overall, Howard E. Davis, Ph.D. has demonstrated expertise in leadership, business development, fundraising, and strategic planning throughout their career in the life sciences industry.

Howard E. Davis, Ph.D. pursued their education with dedication, earning a Bachelor of Science degree in Chemical Engineering from Yale University. Howard E. attended Yale from 1991 to 1995. Howard then went on to excel in the field of Biomedical Engineering, obtaining a Ph.D. from the prestigious Massachusetts Institute of Technology (MIT) from 1995 to 2002. With a strong foundation in Chemical Engineering and an advanced degree in Biomedical Engineering, Howard possesses a diverse and comprehensive educational background.